Atlas Trials

Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)

Clinical trial NCT04717986 · COMPLETED

Trial details

NCT number
NCT04717986
Sponsor
Instituto Mexicano del Seguro Social
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Myocardial InfarctionCardiovascular MorbidityHeart FailureAngina, Unstable
Start date
2021-01-26
Primary completion
2022-06-30
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.